As part of my ongoing relationship with Cycle Pharmaceuticals, I designed the brand for HARLIKU, a treatment for reducing urinary homogentisic acid in adult patients with alkaptonuria, which is an ultra-rare genetic metabolic disorder affecting approximately 1 in 1,000,000 people in the United States of America.
I was asked to create a brand which reflected the simplicity and convenience of the treatment, expressing the brand values of relieving, energising and freeing.
